Antibiotic Resistance Market Size, Industry Analysis, 2026-2034

Table of Contents

1. Introduction
    1.1. Report Description
        1.1.1. Objectives of the Study
        1.1.2. Market Scope
        1.1.3. Assumptions
    1.2. Stakeholders
2. Executive Summary
    2.1. Market Highlights
3. Research Methodology
    3.1. Overview
        3.1.1. Data Mining
    3.2. Data Sources
        3.2.1. Primary Sources
        3.2.2. Secondary Sources
4. Global Antibiotic Resistance Market Insights
    4.1. Antibiotic Resistance Market – Drug Class Snapshot
    4.2. Antibiotic Resistance Market Dynamics
        4.2.1. Drivers and Opportunities
            4.2.1.1. Rising prevalence of antibiotic-resistant and hospital-acquired infections to drive antibiotic resistance market growth
            4.2.1.2. Growing development of new novel antibiotics boosting market’s growth
        4.2.2. Restraints and Challenges
            4.2.2.1. Stringent government regulations and requirements to hamper market growth
    4.3. Porter’s Five Forces Analysis
        4.3.1. Bargaining Power of Suppliers (Moderate)
        4.3.2. Threats of New Entrants: (Low)
        4.3.3. Bargaining Power of Buyers (Moderate)
        4.3.4. Threat of Substitute (Moderate)
        4.3.5. Rivalry among existing firms (High)
    4.4. PESTEL Analysis
    4.5. Antibiotic Resistance Market Drug Class Trends
    4.6. Value Chain Analysis
    4.7. COVID-19 Impact Analysis
5. Global Antibiotic Resistance Market, by Disease
    5.1. Key Findings
    5.2. Introduction
        5.2.1. Global Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
    5.3. cUTI (Complicated Urinary Tract Infections)
        5.3.1. Global Antibiotic Resistance Market, by cUTI (Complicated Urinary Tract Infections), by Region, 2021-2034 (USD Billion)
    5.4. CDI (Clostridioides Difficile Infection)
        5.4.1. Global Antibiotic Resistance Market, by CDI (Clostridioides Difficile Infection), by Region, 2021-2034 (USD Billion)
    5.5. ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
        5.5.1. Global Antibiotic Resistance Market, by ABSSSI (Acute Bacterial Skin and Skin Structure Infections), by Region, 2021-2034 (USD Billion)
    5.6. HABP (Hospital-acquired Bacterial Pneumonia)
        5.6.1. Global Antibiotic Resistance Market, by HABP (Hospital-acquired Bacterial Pneumonia), by Region, 2021-2034 (USD Billion)
    5.7. CABP (Community-acquired Pneumonia)
        5.7.1. Global Antibiotic Resistance Market, by CABP (Community-acquired Pneumonia), by Region, 2021-2034 (USD Billion)
    5.8. cIAI (Complicated Intra-abdominal Infection)
        5.8.1. Global Antibiotic Resistance Market, by cIAI (Complicated Intra-abdominal Infection), by Region, 2021-2034 (USD Billion)
    5.9. BSI (Bloodstream Infection)
        5.9.1. Global Antibiotic Resistance Market, by BSI (Bloodstream Infection), by Region, 2021-2034 (USD Billion)
6. Global Antibiotic Resistance Market, by Distribution Channel
    6.1. Key Findings
    6.2. Introduction
        6.2.1. Global Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
    6.3. Hospital Pharmacies
        6.3.1. Global Antibiotic Resistance Market, by Hospital Pharmacies, by Region, 2021-2034 (USD Billion)
    6.4. Retail Pharmacies
        6.4.1. Global Antibiotic Resistance Market, by Retail Pharmacies, by Region, 2021-2034 (USD Billion)
    6.5. Online Pharmacies
        6.5.1. Global Antibiotic Resistance Market, by Online Pharmacies, by Region, 2021-2034 (USD Billion)
7. Global Antibiotic Resistance Market, by Drug Class
    7.1. Key Findings
    7.2. Introduction
        7.2.1. Global Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
    7.3. Oxazolidinones
        7.3.1. Global Antibiotic Resistance Market, by Oxazolidinones, By Region, 2021-2034 (USD Billion)
    7.4. Lipoglycopeptides
        7.4.1. Global Antibiotic Resistance Market, by Lipoglycopeptides, By Region, 2021-2034 (USD Billion)
    7.5. Tetracyclines
        7.5.1. Global Antibiotic Resistance Market, by Tetracyclines, By Region, 2021-2034 (USD Billion)
    7.6. Combination Therapies
        7.6.1. Global Antibiotic Resistance Market, by Combination Therapies, By Region, 2021-2034 (USD Billion)
    7.7. Cephalosporins
        7.7.1. Global Antibiotic Resistance Market, by Cephalosporins, By Region, 2021-2034 (USD Billion)
    7.8. Others
        7.8.1. Global Antibiotic Resistance Market, by Others, By Region, 2021-2034 (USD Billion)
8. Global Antibiotic Resistance Market, by Geography
    8.1. Key findings
    8.2. Introduction
        8.2.1. Antibiotic Resistance Market Assessment, By Geography, 2021-2034 (USD Billion)
    8.3. Antibiotic Resistance Market – North America
        8.3.1. North America: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
        8.3.2. North America: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
        8.3.3. North America: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.3.4. Antibiotic Resistance Market – U.S.
                    8.3.4.1. U.S.: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                    8.3.4.2. U.S.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
                    8.3.4.3. U.S.: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.3.5. Antibiotic Resistance Market – Canada
            8.3.5.1. Canada: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.3.5.2. Canada.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.3.5.3. Canada: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
    8.4. Antibiotic Resistance Market – Europe
        8.4.1. Europe: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
            8.4.2. Europe.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
        8.4.3. Europe: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.4. Antibiotic Resistance Market – UK
            8.4.4.1. UK: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.4.2. UK.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.4.3. UK: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.5. Antibiotic Resistance Market – France
            8.4.5.1. France: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.5.2. France.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.5.3. France: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.6. Antibiotic Resistance Market – Germany
            8.4.6.1. Germany: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.6.2. Germany.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.6.3. Germany: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.7. Antibiotic Resistance Market – Italy
            8.4.7.1. Italy: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.7.2. Italy.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.7.3. Italy: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.8. Antibiotic Resistance Market – Spain
            8.4.8.1. Spain: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.8.2. Spain.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.8.3. Spain: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.9. Antibiotic Resistance Market – Netherlands
            8.4.9.1. Netherlands: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.9.2. Netherlands.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.9.3. Netherlands: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.10. Antibiotic Resistance Market – Russia
            8.4.10.1. Russia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.4.10.2. Russia.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.4.10.3. Russia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
    8.5. Antibiotic Resistance Market – Asia Pacific
        8.5.1. Asia Pacific: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
        8.5.2. Asia Pacific.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
        8.5.3. Asia Pacific: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.4. Antibiotic Resistance Market – China
            8.5.4.1. China: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.5.4.2. China.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.4.3. China: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.5. Antibiotic Resistance Market – India
            8.5.5.1. India: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.5.5.2. India.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.5.3. India: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.6. Antibiotic Resistance Market – Malaysia
            8.5.6.1. Malaysia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.5.6.2. Malaysia.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.6.3. Malaysia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.7. Antibiotic Resistance Market – Japan
            8.5.7.1. Japan: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.5.7.2. Japan.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.7.3. Japan: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.8. Antibiotic Resistance Market – Indonesia
            8.5.8.1. Indonesia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.5.8.2. Indonesia.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.8.3. Indonesia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.9. Antibiotic Resistance Market – South Korea
            8.5.9.1. South Korea: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
            8.5.9.2. South Korea.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.5.9.3. South Korea: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
    8.6. Antibiotic Resistance Market – Middle East & Africa
        8.6.1. Middle East & Africa: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
        8.6.2. Middle East & Africa.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
        8.6.3. Middle East & Africa: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.6.4. Antibiotic Resistance Market – Saudi Arabia
            8.6.4.1. Saudi Arabia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
            8.6.4.2. Saudi Arabia.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.6.4.3. Saudi Arabia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.6.5. Antibiotic Resistance Market – UAE
            8.6.5.1. UAE: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.6.5.2. UAE.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.6.5.3. UAE: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.6.6. Antibiotic Resistance Market – Israel
            8.6.6.1. Israel: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.6.6.2. Israel.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.6.6.3. Israel: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.6.7. Antibiotic Resistance Market – South Africa
            8.6.7.1. South Africa: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
            8.6.7.2. South Africa.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.6.7.3. South Africa: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
    8.7. Antibiotic Resistance Market – Latin America
        8.7.1. Latin America: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
        8.7.2. Latin America.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
        8.7.3. Latin America: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.7.4. Antibiotic Resistance Market – Mexico
            8.7.4.1. Mexico: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.7.4.2. Mexico.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.7.4.3. Mexico: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.7.5. Antibiotic Resistance Market – Brazil
            8.7.5.1. Brazil: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.7.5.2. Brazil.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.7.5.3. Brazil: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.7.6. Antibiotic Resistance Market – Argentina
            8.7.6.1. Argentina: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
                8.7.6.2. Argentina.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
            8.7.6.3. Argentina: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
9. Competitive Landscape
    9.1. Expansion and Acquisition Analysis
        9.1.1. Expansion
        9.1.2. Acquisitions
    9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
    10.1. Achaogen Inc. (US)
        10.1.1. Company Overview
        10.1.2. Financial Performance
        10.1.3. Product Benchmarking
        10.1.4. Recent Development
   10.2. BioVersys AG (Ireland)
        10.2.1. Company Overview
        10.2.2. Financial Performance
        10.2.3. Product Benchmarking
        10.2.4. Recent Development
    10.3. CARB-X (US)
        10.3.1. Company Overview
        10.3.2. Financial Performance
        10.3.3. Product Benchmarking
        10.3.4. Recent Development
    10.4. Destiny Pharma (UK)
        10.4.1. Company Overview
        10.4.2. Financial Performance
        10.4.3. Product Benchmarking
        10.4.4. Recent Development
    10.5. F. Hoffmann-La Roche Ltd. (Switzerland)
        10.5.1. Company Overview
        10.5.2. Financial Performance
        10.5.3. Product Benchmarking
        10.5.4. Recent Development
    10.6. Johnson & Johnson Services (US)
        10.6.1. Company Overview
        10.6.2. Financial Performance
        10.6.3. Product Benchmarking
        10.6.4. Recent Development
    10.7. Melinta Therapeutics LLC (US)
        10.7.1. Company Overview
        10.7.2. Financial Performance
        10.7.3. Product Benchmarking
        10.7.4. Recent Development
    10.8. Merck & Co. Inc. (Germany)
        10.8.1. Company Overview
        10.8.2. Financial Performance
        10.8.3. Product Benchmarking
        10.8.4. Recent Development
    10.9. Nabriva Therapeutics Plc (Ireland)
        10.9.1. Company Overview
        10.9.2. Financial Performance
        10.9.3. Product Benchmarking
        10.9.4. Recent Development
    10.10. Novartis AG (Switzerland)
        10.10.1. Company Overview
        10.10.2. Financial Performance
        10.10.3. Product Benchmarking
        10.10.4. Recent Development
    10.11. Pfizer Inc. (US)
        10.11.1. Company Overview
        10.11.2. Financial Performance
        10.11.3. Product Benchmarking
        10.11.4. Recent Development
    10.12. The Medicines Company (US)
        10.12.1. Company Overview
        10.12.2. Financial Performance
        10.12.3. Product Benchmarking
        10.12.4. Recent Development
    10.13. Vertex Pharmaceuticals Incorporated (US)
        10.13.1. Company Overview
        10.13.2. Financial Performance
        10.13.3. Product Benchmarking
        10.13.4. Recent Development
    10.14. West Way Health (Ireland)
        10.14.1. Company Overview
        10.14.2. Financial Performance
        10.14.3. Product Benchmarking
        10.14.4. Recent Development

List of Tables

Table 1 Global Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 2 Global Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 3 Global Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 4 Antibiotic Resistance Market Assessment, By Geography, 2021-2034 (USD Billion)
Table 5 North America: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 6 North America: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 7 North America: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 8 U.S.: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 9 U.S.: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 10 U.S.: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 11 Canada: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 12 Canada: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 13 Canada: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 14 Europe: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 15 Europe: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 16 Europe: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 17 UK: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 18 UK: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 19 UK: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 20 France: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 21 France: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 22 France: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 23 Germany: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 24 Germany: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 25 Germany: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 26 Italy: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 27 Italy: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 28 Italy: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 29 Spain: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 30 Spain: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 31 Spain: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 32 Netherlands: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 33 Netherlands: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 34 Netherlands: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 35 Russia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 36 Russia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 37 Russia: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 38 Asia Pacific: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 39 Asia Pacific: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 40 Asia Pacific: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 41 China: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 42 China: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 43 China: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 44 India: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 45 India: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 46 India: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 47 Malaysia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 48 Malaysia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 49 Malaysia: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 50 Japan: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 51 Japan: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 52 Japan: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 53 Indonesia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 54 Indonesia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 55 Indonesia: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 56 South Korea: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 57 South Korea: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 58 South Korea: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 59 Middle East & Africa: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 60 Middle East & Africa: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 61 Middle East & Africa: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 62 Saudi Arabia: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 63 Saudi Arabia: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 64 Saudi Arabia: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 65 UAE: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 66 UAE: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 67 UAE: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 68 Israel: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 69 Israel: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 70 Israel: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 71 South Africa: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 72 South Africa: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 73 South Africa: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 74 Latin America: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 75 Latin America: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 76 Latin America: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 77 Mexico: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 78 Mexico: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 79 Mexico: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 80 Brazil: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 81 Brazil: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 82 Brazil: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)
Table 83 Argentina: Antibiotic Resistance Market, by Disease, 2021-2034 (USD Billion)
Table 84 Argentina: Antibiotic Resistance Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 85 Argentina: Antibiotic Resistance Market, by Drug Class, 2021-2034 (USD Billion)

List of Figures

Figure 1. Global Antibiotic Resistance Market, 2021-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Distribution Channel
Figure 7. Global Antibiotic Resistance Market, by Distribution Channel, 2025 & 2034 (USD Billion)
Figure 8. Market by Disease
Figure 9. Global Antibiotic Resistance Market, by Disease, 2025 & 2034 (USD Billion)
Figure 10. Market by Drug Class
Figure 11. Global Antibiotic Resistance Market, by Drug Class, 2025 & 2034 (USD Billion)
Figure 12. Antibiotic Resistance Market Assessment, By Geography, 2021-2034 (USD Billion)
Figure 13. Strategic Analysis – Antibiotic Resistance Market